Lv11
36 积分 2025-03-24 加入
Lung cancer
59分钟前
待确认
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)]
1小时前
已完结
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
6天前
已完结
Hydrogen bond analysis of the EGFR-ErbB3 heterodimer related to non-small cell lung cancer and drug resistance
6天前
已关闭
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer
6天前
已完结
Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer
6天前
已完结
De-escalation strategies with targeted therapies in non-small cell lung cancer
26天前
已关闭
Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer
26天前
已完结
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
26天前
已关闭
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect
26天前
已完结
皖公网安备34019202002308
